Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
138,154,113
-
Share change
-
+6,705,022
-
Total reported value
-
$269,224,050
-
Put/Call ratio
-
481%
-
Price per share
-
$1.95
-
Number of holders
-
105
-
Value change
-
+$11,071,234
-
Number of buys
-
47
-
Number of sells
-
39
Institutional Holders of VISTAGEN THERAPEUTICS INC - COM NEW (VTGN) as of Q4 2021
As of 31 Dec 2021,
VISTAGEN THERAPEUTICS INC - COM NEW (VTGN) was held by
105 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
138,154,113 shares.
The largest 10 holders included
NEA Management Company, LLC, VR Adviser, LLC, ORBIMED ADVISORS LLC, BlackRock Inc., ACUTA CAPITAL PARTNERS, LLC, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, STATE STREET CORP, COMMODORE CAPITAL LP, and Nicholas Investment Partners, LP.
This page lists
105
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.